The impact of glucagon-like peptide-1 agonists on MGUS progression in patients with type 2 diabetes. This is an ASCO Meeting Abstract from the 2025 ASCO Annual Meeting I. This abstract does not ...

Investigating the tumor microenvironment and neoadjuvant therapy response in HER2-positive breast cancer with invasive micropapillary carcinoma component. This is an ASCO Meeting Abstract from the ...

ROTTERDAM, the Netherlands and SAN DIEGO, Feb. 28, 2025 /PRNewswire/ -- SkylineDx, an innovative diagnostics company specializing in the research and development of molecular diagnostics for oncology, ...

Explore RNA interference methods, comparing siRNA and shRNA for gene knockdown, their mechanisms, advantages, and ...

An exploratory study shows that combining short-term topical microdosing with gene-expression profiling can detect early drug ...

According to clinical guidelines, high-risk myeloma patients should receive intensified treatment regimens. However, heterogeneity in clinical markers and staging systems lead to various ...